Literature DB >> 30653785

Recognizing psychiatric presentations of anti-NMDA receptor encephalitis in children and adolescents: A synthesis of published reports.

Ronald J Gurrera1,2.   

Abstract

AIM: The aim of this study was to improve early recognition of anti-N-methyl-d-aspartate receptor encephalitis (anti-NMDArE) in children and adolescents by identifying characteristic temporal patterns of clinical features in patients likely to be referred for psychiatric evaluation. In this form of autoimmune encephalitis, NMDAr hypofunction is caused by autoantibodies to receptor surface components. Clinical outcomes following prompt immunotherapy are usually good, but delayed treatment often results in a protracted course with significant residual disability or death. Anti-NMDArE frequently mimics psychiatric disorders, so most patients are referred initially to a psychiatrist and treated for days or weeks before being correctly diagnosed.
METHODS: A systematic search of PubMed and EMBASE electronic databases identified all published reports of antibody-confirmed anti-NMDArE associated with psychiatric symptoms in patients <19 years old. Redundant reports were eliminated manually. For each patient, the order in which each feature was first observed was ranked relative to others. Median temporal ranks were used to compare the sequencing of individual features and major symptom domains.
RESULTS: One hundred and sixty seven cases (121 females) met the inclusion criteria. The most common features were dyskinesias (77.8%), seizures (72.5%), mutism or staring (40.7%), insomnia (39.5%), language dysfunction (36.5%), fever (31.1%), disorientation/confusion (28.7%), reduced arousal (28.1%), and memory disturbance (26.9%). The configuration and temporal sequencing of features were highly variable between individuals.
CONCLUSION: Clinicians need to suspect this disorder: if new behavioral symptoms arise in the context of a recent viral prodrome; if they are accompanied by dyskinesias, seizures or insomnia; or if psychiatric symptoms are unusual (e.g., non-verbal auditory hallucinations). Published 2019. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  anti-NMDA; children; diagnosis; encephalitis; receptors

Mesh:

Year:  2019        PMID: 30653785     DOI: 10.1111/pcn.12821

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  6 in total

1.  Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis in Children and Adolescents: A Systematic Review and Quantitative Analysis of Reported Cases.

Authors:  Yam R Giri; Allison Parrill; Sreedevi Damodar; Joshua Fogel; Nisrin Ayed; Muhammad Syed; Ijendu Korie; Sivaranjani Ayyanar; Christopher Typhair; Seema Hashmi
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2021-11-01

Review 2.  Sleep Disturbances Associated with Neurological Autoimmunity.

Authors:  Michelle F Devine; Erik K St Louis
Journal:  Neurotherapeutics       Date:  2021-03-30       Impact factor: 7.620

3.  Altered Behavior in Encephalitis: Insights From the Australian Childhood Encephalitis Study, 2013-2018.

Authors:  Rebecca Burrell; Cheryl A Jones; Philip N Britton
Journal:  Front Pediatr       Date:  2021-12-24       Impact factor: 3.418

4.  Characteristics and outcome-related factors of seizure at the first onset of autoimmune encephalitis: A retrospective study.

Authors:  Yilin Wang; Xin Li; Pingping He; Jiangning Yin; Ruofei Dong; Yu Fu; Hong Zhang
Journal:  CNS Neurosci Ther       Date:  2021-03-08       Impact factor: 5.243

5.  Psychiatric Presentation of Anti-NMDA Receptor Encephalitis.

Authors:  Dominique Endres; Sebastian Rauer; Winfried Kern; Nils Venhoff; Simon J Maier; Kimon Runge; Patrick Süß; Bernd Feige; Kathrin Nickel; Timo Heidt; Katharina Domschke; Karl Egger; Harald Prüss; Philipp T Meyer; Ludger Tebartz van Elst
Journal:  Front Neurol       Date:  2019-11-05       Impact factor: 4.003

Review 6.  Clinical characteristics of anti-N-methyl-D-aspartate receptor encephalitis in patients with a long-term history of mental disorders.

Authors:  Hai-Yang Wang; Xiao-Yu Yang; Jinming Han; Huakun Liu; Zhong-Rui Yan; Zhanhua Liang
Journal:  Eur J Med Res       Date:  2022-03-10       Impact factor: 2.175

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.